BBOT (STOCKS)

    BridgeBio Oncology Therapeutics, Inc. Common Stock

    $12.040000
    +1.200000 (+11.07%)
    Prev close: $10.840000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Eli M. Wallace
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $978.10M
    Employees
    P/E (TTM)
    -12.98
    P/B (TTM)
    1.92
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    5
    Strong Buy
    8
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    $-1.03 $-0.40 -0.6324 -159.05%